NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/23/2024
Back to search
Official data from USPTO
ANAGENEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
07/23/2024
Trademark type
Combined
Nice classes
35, 42
Filing date
06/27/2022
Registration date
07/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/23/2024
Last transaction
07/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/08/2020
First use in commerce
01/08/2020
Drawing code
3
Owner type
03
Owner location
Woburn, MA
Examiner
GEBHARDT, JACQUELINE D
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of three shaded quadrilaterals creating two diagonal lines, with two smaller quadrilaterals touching corners to the left of a longer quadrilateral, above the literal element "ANAGENEX".
Holders and representatives
Holders
Anagenex, Inc.
Representatives
Niq Howard
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing advertisingmarketing and promotional services for the pharmaceutical and medical industry; Providing advertisingmarketing and promotional services for the pharmaceutical and medical products of others; Providing business intelligence services in the fields of medical devicespharmaceuticals and the life sciences
Class 42
Providing a website featuring non-downloadable software using artificial intelligence for finding and marketing FDA approved pharmaceuticals to patients; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2024
PUBO
PUBLISHED FOR OPPOSITION
05/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2024
ALIE
ASSIGNED TO LIE
03/11/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/23/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/26/2023
GNFR
FINAL REFUSAL E-MAILED
07/26/2023
CNFR
FINAL REFUSAL WRITTEN
07/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/11/2023
GNRT
NON-FINAL ACTION E-MAILED
04/11/2023
CNRT
NON-FINAL ACTION WRITTEN
04/11/2023
DOCK
ASSIGNED TO EXAMINER
03/30/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2022
NWAP
NEW APPLICATION ENTERED
06/30/2022
Continuous trademark protection
Get notified about every new filing that threatens ANAGENEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.